Dancing with sex hormones, could iron contribute to the gender difference in osteoporosis?

Bone

Volumn 55, Issue 2, 2013, Pages 458-460

  Huang, Xi ^a   Xu, Youjia ^b   Partridge, Nicola C ^c  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b THE SECOND AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

^c NEW YORK UNIVERSITY COLLEGE OF DENTISTRY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; ESTROGEN; FERRITIN; FORKHEAD TRANSCRIPTION FACTOR; IRON; REACTIVE OXYGEN METABOLITE; SEX HORMONE; TESTOSTERONE; WNT PROTEIN;

AGING; BONE DENSITY; BONE MASS; BONE METABOLISM; BONE TURNOVER; CORRELATION ANALYSIS; EDITORIAL; ESTROGEN BLOOD LEVEL; ESTROGEN DEFICIENCY; FEMALE; FERRITIN BLOOD LEVEL; GENETIC VARIABILITY; HERITABILITY; HUMAN; INCIDENCE; IRON BLOOD LEVEL; MALE; MENOPAUSE; NONHUMAN; OSSIFICATION; OSTEOLYSIS; OSTEOPOROSIS; PHASE TRANSITION; POSTMENOPAUSE OSTEOPOROSIS; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; TESTOSTERONE BLOOD LEVEL; WNT SIGNALING PATHWAY;

FEMALE; FERRITINS; GONADAL STEROID HORMONES; HUMANS; IRON; MALE; OSTEOPOROSIS; SEX CHARACTERISTICS;

EID: 84878950141     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2013.03.008     Document Type: Editorial

References (23)

1. Nielson C.M., Klein R.F., Orwoll E.S. Sex and the single nucleotide polymorphism: exploring the genetic causes of skeletal sex differences. J Bone Miner Res 2012, 27:2047-2050.
2. Liu C.T., Estrada K., Yerges-Armstrong L.M., Amin N., Evangelou E., Li G., et al. Assessment of gene-by-sex interaction effect on bone mineral density. J Bone Miner Res 2012, 27:2051-2064.
3. Harrison P.M., Arosio P. The ferritins: molecular properties, iron storage function and cellular regulation. Biochim Biophys Acta 1996, 1275:161-203.
4. Jian J., Pelle E., Huang X. Iron and menopause: does increased iron affect the health of postmenopausal women?. Antioxid Redox Signal 2009, 11:2939-2943.
5. Guggenbuhl P., Fergelot P., Doyard M., Libouban H., Roth M.P., Gallois Y., et al. Bone status in a mouse model of genetic hemochromatosis. Osteoporos Int 2011, 22:2313-2319.
6. Ishii K.A., Fumoto T., Iwai K., Takeshita S., Ito M., Shimohata N., et al. Coordination of PGC-1beta and iron uptake in mitochondrial biogenesis and osteoclast activation. Nat Med 2009, 15:259-266.
7. Tsay J., Yang Z., Ross F.P., Cunningham-Rundles S., Lin H., Coleman R., et al. Bone loss caused by iron overload in a murine model: importance of oxidative stress. Blood 2010, 116:2582-2589.
8. Yang Q., Jian J., Abramson S.B., Huang X. Inhibitory effects of iron on bone morphogenetic protein 2-induced osteoblastogenesis. J Bone Miner Res 2011, 26:1188-1196.
9. Zarjou A., Jeney V., Arosio P., Poli M., Zavaczki E., Balla G., et al. Ferritin ferroxidase activity: a potent inhibitor of osteogenesis. J Bone Miner Res 2010, 25:164-172.
10. Kim B.J., Ahn S.H., Bae S.J., Kim E.H., Lee S.H., Kim H.K., et al. Iron overload accelerates bone loss in healthy postmenopausal women and middle-aged men: a 3-year retrospective longitudinal study. J Bone Miner Res 2012, 27:2279-2290.
11. Zimmermann M.B., Hurrell R.F. Nutritional iron deficiency. Lancet 2007, 370:511-520.
12. Milman N., Kirchhoff M. Iron stores in 1359, 30- to 60-year-old Danish women: evaluation by serum ferritin and hemoglobin. Ann Hematol 1992, 64:22-27.
13. Zacharski L.R., Ornstein D.L., Woloshin S., Schwartz L.M. Association of age, sex, and race with body iron stores in adults: analysis of NHANES III data. Am Heart J 2000, 140:98-104.
14. Milman N. Serum ferritin in Danes: studies of iron status from infancy to old age, during blood donation and pregnancy. Int J Hematol 1996, 63:103-135.
15. Riggs B.L., Khosla S., Melton L.J. Estrogen, bone homeostasis, and osteoporosis. Osteoporosis 2008, 1011-1039. Elsevier, New York. R. Marcus, D. Feldman, D. Nelson, C.J. Rosen (Eds.).
16. Riggs B.L., Khosla S., Melton L.J. Sex steroids and the construction and conservation of the adult skeleton. Endocr Rev 2002, 23:279-302.
17. Khosla S. The effects of androgens on osteoblast function in vitro. Mayo Clin Proc 2000, 75:S51-S54. [Suppl.].
18. Ganz T., Nemeth E. Hepcidin and disorders of iron metabolism. Annu Rev Med 2011, 62:347-360.
19. Yang Q., Jian J., Katz S., Abramson S.A., Huang X. Estrogen inhibits iron hormone hepcidin through an estrogen responsive element half-site. Endocrinology 2012, 153:3170-3178.
20. Milman N., Kirchhoff M., Jorgensen T. Iron status markers, serum ferritin and hemoglobin in 1359 Danish women in relation to menstruation, hormonal contraception, parity, and postmenopausal hormone treatment. Ann Hematol 1992, 65:96-102.
21. Mattace Raso G., Irace C., Esposito E., Maffettone C., Iacono A., Di Pascale A., et al. Ovariectomy and estrogen treatment modulate iron metabolism in rat adipose tissue. Biochem Pharmacol 2009, 78:1001-1007.
22. Li G.F., Pan Y.Z., Sirois P., Li K., Xu Y.J. Iron homeostasis in osteoporosis and its clinical implications. Osteoporos Int 2012, 23:2403-2408.
23. Almeida M., Han L., Martin-Millan M., O'Brien C.A., Manolagas S.C. Oxidative stress antagonizes Wnt signaling in osteoblast precursors by diverting beta-catenin from T cell factor- to forkhead box O-mediated transcription. J Biol Chem 2007, 282:27298-27305.